XML 90 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting
12 Months Ended
Dec. 31, 2012
Segment Reporting  
Segment Reporting

14          Segment Reporting

 

The Company currently has three reportable segments: Pharmacy Services, Retail Pharmacy and Corporate.

 

The Company evaluates its Pharmacy Services and Retail Pharmacy segment performance based on net revenue, gross profit and operating profit before the effect of certain intersegment activities and charges. The Company evaluates the performance of its Corporate Segment based on operating expenses before the effect of discontinued operations and certain intersegment activities and charges. See Note 1 for a description of the Pharmacy Services, Retail Pharmacy and Corporate segments and related significant accounting policies.

 

The following table is a reconciliation of the Company’s business segments to the consolidated financial statements:

 

In millions

 

Pharmacy Services
Segment(1)(2)

 

Retail Pharmacy
Segment(2)

 

Corporate
Segment

 

Intersegment
Eliminations(2)

 

Consolidated
Totals

 

2012:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

73,444

 

$

63,654

 

$

 

$

(13,965

)

$

123,133

 

Gross profit

 

3,808

 

19,109

 

 

(411

)

22,506

 

Operating profit

 

2,679

 

5,654

 

(694

)

(411

)

7,228

 

Depreciation and amortization

 

517

 

1,153

 

83

 

 

1,753

 

Total assets

 

36,057

 

29,183

 

1,408

 

(736

)

65,912

 

Goodwill

 

19,646

 

6,749

 

 

 

26,395

 

Additions to property and equipment

 

422

 

1,555

 

53

 

 

2,030

 

2011:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

58,874

 

$

59,599

 

$

 

$

(11,373

)

$

107,100

 

Gross profit

 

3,279

 

17,468

 

 

(186

)

20,561

 

Operating profit

 

2,220

 

4,912

 

(616

)

(186

)

6,330

 

Depreciation and amortization

 

433

 

1,060

 

75

 

 

1,568

 

Total assets

 

35,704

 

28,323

 

1,121

 

(605

)

64,543

 

Goodwill

 

19,657

 

6,801

 

 

 

26,458

 

Additions to property and equipment

 

461

 

1,353

 

58

 

 

1,872

 

2010:

 

 

 

 

 

 

 

 

 

 

 

Net revenues

 

$

47,145

 

$

57,345

 

$

 

$

(8,712

)

$

95,778

 

Gross profit

 

3,315

 

17,039

 

 

(135

)

20,219

 

Operating profit

 

2,361

 

4,537

 

(626

)

(135

)

6,137

 

Depreciation and amortization

 

390

 

1,016

 

63

 

 

1,469

 

Total assets

 

32,254

 

28,927

 

1,439

 

(451

)

62,169

 

Goodwill

 

18,868

 

6,801

 

 

 

25,669

 

Additions to property and equipment

 

234

 

1,708

 

63

 

 

2,005

 

 

 

(1)         Net revenues of the Pharmacy Services Segment include approximately $8.4 billion, $7.9 billion and $6.6 billion of Retail co-payments for the years ended December 31, 2012, 2011 and 2010, respectively.

 

(2)         Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment clients use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy Segments record the revenue on a standalone basis and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment clients, through the Company’s intersegment activities (such as the Maintenance Choice program), elect to pick up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. Beginning in the fourth quarter of 2011, the Maintenance Choice eliminations reflect all discounts available for the purchase of mail order prescription drugs. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $3.4 billion, $2.6 billion and $1.8 billion for the years ended December 31, 2012, 2011 and 2010, respectively; gross profit and operating profit of $411 million, $186 million and $135 million for the years ended December 31, 2012, 2011 and 2010, respectively.